Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

NVSI-06-08 is a potential broad-spectrum recombinant COVID-19 vaccine that integrates the antigens from multiple SARS-CoV-2 strains into a single immunogen. Here, we evaluate the safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in BBIBP-CorV recipients in a randomized, double-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaabi, Nawal Al, Yang, Yun Kai, Du, Li Fang, Xu, Ke, Shao, Shuai, Liang, Yu, Kang, Yun, Su, Ji Guo, Zhang, Jing, Yang, Tian, Hussein, Salah, ElDein, Mohamed Saif, Yang, Sen Sen, Lei, Wenwen, Gao, Xue Jun, Jiang, Zhiwei, Cong, Xiangfeng, Tan, Yao, Wang, Hui, Li, Meng, Mekki, Hanadi Mekki, Zaher, Walid, Mahmoud, Sally, Zhang, Xue, Qu, Chang, Liu, Dan Ying, Yang, Mengjie, Eltantawy, Islam, Hou, Jun Wei, Lei, Ze Hua, Xiao, Peng, Wang, Zhao Nian, Yin, Jin Liang, Mao, Xiao Yan, Zhang, Jin, Qu, Liang, Zhang, Yun Tao, Yang, Xiao Ming, Wu, Guizhen, Li, Qi Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237056/
https://www.ncbi.nlm.nih.gov/pubmed/35760812
http://dx.doi.org/10.1038/s41467-022-31379-0

Ejemplares similares

Ejemplares similares